Product news

Share this article:

Xanodyne Pharmaceuticals has received an approvable letter from the FDA for Zipsor, indicated for mild to moderate acute pain. Zipsor is an immediate release liquid-filled soft gelatin capsule containing 25 mg of diclofenac potassium, for oral administration.   

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions